Reduced administration of rasburicase for tumor lysis syndrome: A singleinstitution experience

Author：                    

Publisher： Spandidos Publications

E-ISSN： 1792-1082|9|5|2119-2125

ISSN： 1792-1074

Source： Oncology Letters, Vol.9, Iss.5, 2015-01, pp. : 2119-2125

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tumor Lysis Syndrome in Small Cell Lung Cancer

By Kallab A.M.   Jillella A.P.  

Medical Oncology, Vol. 18, Iss. 2, 2001-03 ,pp. : 149-151

Humana Press, Inc

Access to resources Recommend Favorite

Tumour lysis syndrome in multiple myeloma after bortezomib (VELCADE) administration

By Terpos Evangelos   Politou Marianna   Rahemtulla Amin  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 10, 2004-10 ,pp. : 623-625

Springer Publishing Company

Access to resources Recommend Favorite

Tumor lysis syndrome after treatment with gemcitabine for metastatic transitional cell carcinoma

By Lin Cheng-Jui   Lim Ken-Hong   Cheng Yi-Chou   Chen Han-Hsiang   Wu Chih-Jen  

Medical Oncology, Vol. 24, Iss. 4, 2007-12 ,pp. : 455-457

Humana Press, Inc

Access to resources Recommend Favorite

Cutaneous metastatic adenocarcinoma complicated by spontaneous tumor lysis syndrome: A case report

By Wang Yu   Yuan Caijun   Liu Xiaomei  

Oncology Letters, Vol. 8, Iss. 2, 2014-08 ,pp. : 905-907

Spandidos Publications

Access to resources Recommend Favorite

Tumor lysis syndrome following docetaxel therapy for extensive metastatic prostate cancer

By Sorscher Steven  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 2, 2004-08 ,pp. : 191-192

Springer Publishing Company

Access to resources Recommend Favorite